DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 119 filers reported holding DENALI THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.75 and the average weighting 0.7%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 7,460,732 | $219,569,000 | 28.65% |
ARCH Venture Management, LLC | 5,168,749 | $152,116,000 | 18.54% |
Casdin Capital, LLC | 1,500,000 | $44,145,000 | 3.73% |
Flagship Pioneering Inc. | 2,619,968 | $77,106,000 | 2.90% |
Yiheng Capital Management, L.P. | 1,014,684 | $29,862,000 | 1.71% |
SECTORAL ASSET MANAGEMENT INC | 202,100 | $5,948,000 | 1.20% |
GILDER GAGNON HOWE & CO LLC | 1,956,820 | $57,589,000 | 1.03% |
Artal Group S.A. | 600,000 | $17,658,000 | 0.94% |
Temasek Holdings (Private) Ltd | 5,369,487 | $158,024,002 | 0.87% |
BRANDYWINE MANAGERS, LLC | 9,601 | $283,000 | 0.69% |